Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema

NCT04018833 is registered in ClinicalTrials.gov with Bernardete Pessoa MD as lead sponsor.

NCT NCT04018833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04018833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema
Lead sponsor
Bernardete Pessoa MD
Phase
Observational
Overall status
Completed
Start date
January 1, 2012
Completion date
June 30, 2016
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy